Found: 95
Select item for more details and to access through your institution.
Effect of Secukinumab on the Different GRAPPA-OMERACT Core Domains in Psoriatic Arthritis: A Pooled Analysis of 2049 Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2012, v. 27, n. 1, p. 24, doi. 10.1002/hup.1254
- By:
- Publication type:
- Article
Minimal evolution time and quantum speed limit of non-Markovian open systems.
- Published in:
- Scientific Reports, 2015, p. 16357, doi. 10.1038/srep16357
- By:
- Publication type:
- Article
Patient reported outcomes and performance metrics at diagnosis of secondary progressive multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 5, p. 742, doi. 10.1177/1352458520936214
- By:
- Publication type:
- Article
Rivastigmine Transdermal Patch Skin Tolerability: Results of a 1-Year Clinical Trial in Patients with Mild-to-Moderate Alzheimer's Disease.
- Published in:
- Clinical Drug Investigation, 2010, v. 30, n. 1, p. 41, doi. 10.2165/11531270-000000000-00000
- By:
- Publication type:
- Article
The nature and nurture of network evolution.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42856-5
- By:
- Publication type:
- Article
Fragmentation of outage clusters during the recovery of power distribution grids.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-35104-9
- By:
- Publication type:
- Article
COVID-19 and Consumer Finance: Guest Editors' Introduction.
- Published in:
- Journal of Financial Counseling & Planning, 2024, v. 35, n. 2, p. 155, doi. 10.1891/JFCP-2024-0043
- By:
- Publication type:
- Article
Credit Card Usage Among College Students in China.
- Published in:
- Journal of Financial Counseling & Planning, 2018, v. 29, n. 2, p. 304, doi. 10.1891/1052-3073.29.2.304
- By:
- Publication type:
- Article
Prediction of risk for secondary lower respiratory tract fungal infection during the acute exacerbation phase of COPD.
- Published in:
- Journal of Infection in Developing Countries, 2023, v. 17, n. 2, p. 268, doi. 10.3855/jidc.16088
- By:
- Publication type:
- Article
An analysis of bundle pricing: the case of biotech seeds.
- Published in:
- Agricultural Economics, 2012, v. 43, p. 125, doi. 10.1111/j.1574-0862.2012.00627.x
- By:
- Publication type:
- Article
Impact of Switching to Fingolimod Versus Injectable Disease-Modifying Therapy Cycling on Risk of Multiple Sclerosis-Related Relapses: A Retrospective Analysis.
- Published in:
- International Journal of MS Care, 2021, v. 23, n. 2, p. 73, doi. 10.7224/1537-2073.2019-050
- By:
- Publication type:
- Article
(DXT78) The FLUENT Study: Changes in Immune Cell Profile, and in Clinical and Safety Outcomes, in Fingolimod-Treated Patients with Relapsing Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 44
- By:
- Publication type:
- Article
(DXT60) Correlations Between Four Common Measures of Cognition in Patients with Secondary Progressive Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 37
- By:
- Publication type:
- Article
(DXT43) Analyses of the Effect of Baseline Age on the Efficacy and Safety of Siponimod in Patients with Active Secondary Progressive Multiple Sclerosis from the EXPAND Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 31
- By:
- Publication type:
- Article
(DXT24) Two Expanded Disability Status Scale Subscales Evaluated in Patients with Relapsing-Remitting or Secondary Progressive Multiple Sclerosis.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 24
- By:
- Publication type:
- Article
(DXT03) Analyses of the Effect of Disease Duration on the Efficacy and Safety of Siponimod in Patients with Active Secondary Progressive Multiple Sclerosis from the EXPAND Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 16
- By:
- Publication type:
- Article
(DXT04) Siponimod First-Dose Effects in Patients with Secondary Progressive Multiple Sclerosis Receiving Concomitant Selective Serotonin Reuptake Inhibitor Therapy.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 17
- By:
- Publication type:
- Article
Laodelphax striatellus saliva mucin enables the formation of stylet sheathes to facilitate its feeding and rice stripe virus transmission.
- Published in:
- Pest Management Science, 2022, v. 78, n. 8, p. 3498, doi. 10.1002/ps.6990
- By:
- Publication type:
- Article
Rivastigmine in moderately severe-to-severe Alzheimer's disease: Severe Impairment Battery factor analysis.
- Published in:
- Alzheimer's Research & Therapy, 2013, v. 5, n. 6, p. 2, doi. 10.1186/alzrt229
- By:
- Publication type:
- Article
Effect of doramectin on programmed cell death pathway in glioma cells.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 10, p. 2871, doi. 10.1007/s12094-023-03147-z
- By:
- Publication type:
- Article
Joint Feature-Space and Sample-Space Based Heterogeneous Feature Transfer Method for Object Recognition Using Remote Sensing Images with Different Spatial Resolutions.
- Published in:
- Sensors (14248220), 2021, v. 21, n. 22, p. 7568, doi. 10.3390/s21227568
- By:
- Publication type:
- Article
Immune cell subset profiling in multiple sclerosis after fingolimod initiation and continued treatment: The FLUENT study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2022, v. 8, n. 3, p. 1, doi. 10.1177/20552173221115023
- By:
- Publication type:
- Article
The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217318819245
- By:
- Publication type:
- Article
Patient-Reported Disease-Modifying Therapy Adherence in the Clinic: A Reliable Metric?
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318777894
- By:
- Publication type:
- Article
Breakpoint Planning Method for Rice Multibreak Milling.
- Published in:
- Foods, 2023, v. 12, n. 9, p. 1864, doi. 10.3390/foods12091864
- By:
- Publication type:
- Article
Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2018, v. 8, n. 1, p. 17, doi. 10.1007/s13555-017-0211-4
- By:
- Publication type:
- Article
Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2016, v. 6, n. 4, p. 627, doi. 10.1007/s13555-016-0139-0
- By:
- Publication type:
- Article
Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2016, v. 6, n. 4, p. 639, doi. 10.1007/s13555-016-0140-7
- By:
- Publication type:
- Article
Efficacy of Rivastigmine on Executive Function in Patients with Parkinson's Disease Dementia F. A. Schmitt et al. Efficacy of Rivastigmine on EF in Patients with PDD.
- Published in:
- CNS Neuroscience & Therapeutics, 2010, v. 16, n. 6, p. 330, doi. 10.1111/j.1755-5949.2010.00182.x
- By:
- Publication type:
- Article
The Impact of Financial Software Use on Financial Literacy Education - Evidence from China.
- Published in:
- Journal of Personal Finance, 2020, v. 19, n. 1, p. 81
- By:
- Publication type:
- Article
Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and Safety of Fingolimod in Hispanic Patients with Multiple Sclerosis: Pooled Clinical Trial Analyses.
- Published in:
- Advances in Therapy, 2014, v. 31, n. 10, p. 1072, doi. 10.1007/s12325-014-0154-4
- By:
- Publication type:
- Article
Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cognitive Efficacy (SIB) of 13.3 Versus 4.6 mg/24 h Rivastigmine Patch in Severe Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2016, v. 31, n. 3, p. 270, doi. 10.1177/1533317515603687
- By:
- Publication type:
- Article
Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia: An ADAS-Cog Factor Analysis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Rivastigmine in Alzheimer’s Disease and Parkinson’s Disease Dementia: An ADAS-Cog Factor Analysis.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2011, v. 26, n. 6, p. 443, doi. 10.1177/1533317511424892
- By:
- Publication type:
- Article
Impact of Rivastigmine Patch and Capsules on Activities of Daily Living in Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2011, v. 26, n. 1, p. 65, doi. 10.1177/1533317510391240
- By:
- Publication type:
- Article
Reviews: Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer’s Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2010, v. 25, n. 8, p. 627, doi. 10.1177/1533317510385808
- By:
- Publication type:
- Article
Evaluating Rivastigmine in Mild-to-Moderate Parkinson's Disease Dementia Using ADAS-Cog Items.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2010, v. 25, n. 5, p. 407, doi. 10.1177/1533317510367486
- By:
- Publication type:
- Article
Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2010, v. 25, n. 4, p. 347, doi. 10.1177/1533317510365344
- By:
- Publication type:
- Article
Switching from Donepezil Tablets to Rivastigmine Transdermal Patch in Alzheimer's Disease.
- Published in:
- American Journal of Alzheimer's Disease & Other Dementias, 2009, v. 24, n. 3, p. 267
- By:
- Publication type:
- Article
Efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on activities of daily living in severe Alzheimer's disease.
- Published in:
- SAGE Open Medicine, 2014, v. 2, p. 1, doi. 10.1177/2050312114561569
- By:
- Publication type:
- Article
Land rental market and rural household efficiency in China.
- Published in:
- Environment & Development Economics, 2022, v. 27, n. 2, p. 103, doi. 10.1017/S1355770X20000583
- By:
- Publication type:
- Article
Lewis Acid Doping Induced Synergistic Effects on Electronic and Morphological Structure for Donor and Acceptor in Polymer Solar Cells.
- Published in:
- Advanced Energy Materials, 2018, v. 8, n. 19, p. 1, doi. 10.1002/aenm.201703672
- By:
- Publication type:
- Article
8.0% Efficient All-Polymer Solar Cells with High Photovoltage of 1.1 V and Internal Quantum Efficiency near Unity.
- Published in:
- Advanced Energy Materials, 2018, v. 8, n. 1, p. n/a, doi. 10.1002/aenm.201700908
- By:
- Publication type:
- Article
Ternary Organic Solar Cells with Minimum Voltage Losses.
- Published in:
- Advanced Energy Materials, 2017, v. 7, n. 21, p. n/a, doi. 10.1002/aenm.201700390
- By:
- Publication type:
- Article
Triperylene Hexaimides Based All-Small-Molecule Solar Cells with an Efficiency over 6% and Open Circuit Voltage of 1.04 V.
- Published in:
- Advanced Energy Materials, 2017, v. 7, n. 6, p. n/a, doi. 10.1002/aenm.201601664
- By:
- Publication type:
- Article